$550,000 Aggregate Market Value estimated based on $2.75 price, assumes no shares sold at higher prices. 200,000 shares are being sold in accordance with a 10b5-1 plan, subject to certain volume restrictions and in compliance with Rule 144. Acquisition Date and Payment Date represent the date the Series C-2 Preferred stock was purchased, which was converted to Common Stock on September 14, 2021.

02/14/2025

11/19/2024

/s/ Charles Allen